Published in FASEB J on June 12, 2012
Multiple phenotypes in phosphoglucomutase 1 deficiency. N Engl J Med (2014) 2.62
Mutations in STT3A and STT3B cause two congenital disorders of glycosylation. Hum Mol Genet (2013) 0.98
A new congenital disorder of glycosylation caused by a mutation in SSR4, the signal sequence receptor 4 protein of the TRAP complex. Hum Mol Genet (2013) 0.85
A catalytically essential motif in external loop 5 of the bacterial oligosaccharyltransferase PglB. J Biol Chem (2013) 0.81
Development of isoform-specific sensors of polypeptide GalNAc-transferase activity. J Biol Chem (2014) 0.78
Glycosylation and stem cells: Regulatory roles and application of iPSCs in the study of glycosylation-related disorders. Bioessays (2016) 0.75
Glycomic Characterization of Induced Pluripotent Stem Cells Derived from a Patient Suffering from Phosphomannomutase 2 Congenital Disorder of Glycosylation (PMM2-CDG). Mol Cell Proteomics (2016) 0.75
N-Glycoprofiling Analysis for Carbohydrate Composition and Site-Occupancy Determination in a Poly-Glycosylated Protein: Human Thyrotropin of Different Origins. Int J Mol Sci (2017) 0.75
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer. Curr Biol (1996) 9.72
The molecular structure of green fluorescent protein. Nat Biotechnol (1996) 9.63
A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell (2010) 7.51
Chemical structure of the hexapeptide chromophore of the Aequorea green-fluorescent protein. Biochemistry (1993) 4.74
Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest (2010) 3.91
Green fluorescent protein (GFP): applications, structure, and related photophysical behavior. Chem Rev (2002) 3.46
Induced pluripotent stem cells--opportunities for disease modelling and drug discovery. Nat Rev Drug Discov (2011) 2.58
Congenital disorders of glycosylation: an update on defects affecting the biosynthesis of dolichol-linked oligosaccharides. Hum Mutat (2009) 2.03
Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat Protoc (2010) 1.93
Congenital disorders of glycosylation. Ann N Y Acad Sci (2010) 1.93
Carbohydrate deficient serum transferrin in a new systemic hereditary syndrome. Arch Dis Child (1990) 1.38
The congenital disorders of glycosylation: a multifaceted group of syndromes. NeuroRx (2006) 1.33
Congenital Disorders of Glycosylation: CDG-I, CDG-II, and beyond. Curr Mol Med (2007) 1.27
Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome. Biochem Biophys Res Commun (1992) 1.23
Phosphomannose isomerase inhibitors improve N-glycosylation in selected phosphomannomutase-deficient fibroblasts. J Biol Chem (2011) 1.19
Clinical and molecular characterization of the first adult congenital disorder of glycosylation (CDG) type Ic patient. Am J Med Genet A (2005) 1.16
Engineered metal binding sites on green fluorescence protein. Biochem Biophys Res Commun (2000) 1.13
Hydrophobic Man-1-P derivatives correct abnormal glycosylation in Type I congenital disorder of glycosylation fibroblasts. Glycobiology (2005) 1.12
Screening and diagnosis of congenital disorders of glycosylation. Clin Chim Acta (2007) 1.11
Molecular imaging of N-linked glycosylation suggests glycan biosynthesis is a novel target for cancer therapy. Clin Cancer Res (2010) 1.10
Differential effects of lobe A and lobe B of the Conserved Oligomeric Golgi complex on the stability of {beta}1,4-galactosyltransferase 1 and {alpha}2,6-sialyltransferase 1. Glycobiology (2010) 1.00
The efficiency of N-linked glycosylation of bovine DNase I depends on the Asn-Xaa-Ser/Thr sequence and the tissue of origin. Biochem J (2001) 0.95
Flow cytometric analysis of the cell cycle in transfected cells without cell fixation. Biotechniques (1999) 0.89
Rational design of green fluorescent protein mutants as biosensor for bacterial endotoxin. Protein Eng (2002) 0.89
Cell-based assays in practice: cell markers from autofluorescent proteins of the GFP-family. Comb Chem High Throughput Screen (2008) 0.80
Successful treatment of carbohydrate deficient glycoprotein syndrome type 1b with oral mannose. Arch Dis Child (2001) 0.79
Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol (2008) 3.91
Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder. Nat Med (2004) 3.06
Multiple phenotypes in phosphoglucomutase 1 deficiency. N Engl J Med (2014) 2.62
SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder. Cell (2010) 2.49
Murine features of neurogenesis in the human hippocampus across the lifespan from 0 to 100 years. PLoS One (2010) 2.34
RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis (2008) 2.33
Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. Cancer Res (2007) 2.10
Neurology of inherited glycosylation disorders. Lancet Neurol (2012) 1.82
Directed differentiation of human embryonic stem cells toward chondrocytes. Nat Biotechnol (2010) 1.72
Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia (2009) 1.66
Symbol nomenclature for glycan representation. Proteomics (2009) 1.56
Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function. J Clin Invest (2008) 1.52
N -Glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth. J Neurochem (2002) 1.51
CDG nomenclature: time for a change! Biochim Biophys Acta (2009) 1.49
COG8 deficiency causes new congenital disorder of glycosylation type IIh. Hum Mol Genet (2007) 1.41
Mutations in the glycosylphosphatidylinositol gene PIGL cause CHIME syndrome. Am J Hum Genet (2012) 1.38
Deficiency of UDP-GlcNAc:Dolichol Phosphate N-Acetylglucosamine-1 Phosphate Transferase (DPAGT1) causes a novel congenital disorder of Glycosylation Type Ij. Hum Mutat (2003) 1.36
A novel cerebello-ocular syndrome with abnormal glycosylation due to abnormalities in dolichol metabolism. Brain (2010) 1.34
The congenital disorders of glycosylation: a multifaceted group of syndromes. NeuroRx (2006) 1.33
Glycosylation diseases: quo vadis? Biochim Biophys Acta (2008) 1.30
Neurological aspects of human glycosylation disorders. Annu Rev Neurosci (2015) 1.27
E-cadherin inhibits cell surface localization of the pro-migratory 5T4 oncofetal antigen in mouse embryonic stem cells. Mol Biol Cell (2007) 1.26
Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells. Cancer Res (2008) 1.26
TMEM165 deficiency causes a congenital disorder of glycosylation. Am J Hum Genet (2012) 1.20
Expanding spectrum of congenital disorder of glycosylation Ig (CDG-Ig): sibs with a unique skeletal dysplasia, hypogammaglobulinemia, cardiomyopathy, genital malformations, and early lethality. Am J Med Genet A (2007) 1.20
Phosphomannose isomerase inhibitors improve N-glycosylation in selected phosphomannomutase-deficient fibroblasts. J Biol Chem (2011) 1.19
Congenital disorder of glycosylation (CDG)-Ih patient with a severe hepato-intestinal phenotype and evolving central nervous system pathology. J Pediatr (2005) 1.18
Ablation of mouse phosphomannose isomerase (Mpi) causes mannose 6-phosphate accumulation, toxicity, and embryonic lethality. J Biol Chem (2005) 1.16
Clinical and molecular characterization of the first adult congenital disorder of glycosylation (CDG) type Ic patient. Am J Med Genet A (2005) 1.16
Targeted polymerase chain reaction-based enrichment and next generation sequencing for diagnostic testing of congenital disorders of glycosylation. Genet Med (2011) 1.15
Carboxylated glycans mediate colitis through activation of NF-kappa B. J Immunol (2005) 1.12
Hydrophobic Man-1-P derivatives correct abnormal glycosylation in Type I congenital disorder of glycosylation fibroblasts. Glycobiology (2005) 1.12
Clinical and biochemical characterization of a patient with congenital disorder of glycosylation (CDG) IIx. J Pediatr (2005) 1.12
Molecular imaging of N-linked glycosylation suggests glycan biosynthesis is a novel target for cancer therapy. Clin Cancer Res (2010) 1.10
DDOST mutations identified by whole-exome sequencing are implicated in congenital disorders of glycosylation. Am J Hum Genet (2012) 1.09
Molecular and clinical characterization of a Moroccan Cog7 deficient patient. Mol Genet Metab (2007) 1.09
Glycobiology of neuromuscular disorders. Glycobiology (2003) 1.08
BMP4-directed trophoblast differentiation of human embryonic stem cells is mediated through a ΔNp63+ cytotrophoblast stem cell state. Development (2013) 1.07
GLUT14, a duplicon of GLUT3, is specifically expressed in testis as alternative splice forms. Genomics (2002) 1.07
Identification of a frequent variant in ALG6, the cause of Congenital Disorder of Glycosylation-Ic. Hum Mutat (2003) 1.05
Carboxylated N-glycans on RAGE promote S100A12 binding and signaling. J Cell Biochem (2010) 1.05
Heparan sulfate plays a central role in a dynamic in vitro model of protein-losing enteropathy. J Biol Chem (2006) 1.03
Agm1/Pgm3-mediated sugar nucleotide synthesis is essential for hematopoiesis and development. Mol Cell Biol (2007) 1.03
Mosaicism of the UDP-galactose transporter SLC35A2 causes a congenital disorder of glycosylation. Am J Hum Genet (2013) 1.03
Inflammation as a matchmaker: revisiting cell fusion. Nat Cell Biol (2008) 1.00
Congenital disorder of glycosylation id presenting with hyperinsulinemic hypoglycemia and islet cell hyperplasia. J Clin Endocrinol Metab (2005) 0.99
Golgi glycosylation and human inherited diseases. Cold Spring Harb Perspect Biol (2011) 0.99
The relative contribution of mannose salvage pathways to glycosylation in PMI-deficient mouse embryonic fibroblast cells. FEBS J (2008) 0.99
A zebrafish model of PMM2-CDG reveals altered neurogenesis and a substrate-accumulation mechanism for N-linked glycosylation deficiency. Mol Biol Cell (2012) 0.99
Mutations in STT3A and STT3B cause two congenital disorders of glycosylation. Hum Mol Genet (2013) 0.98
Identification of intercellular cell adhesion molecule 1 (ICAM-1) as a hypoglycosylation marker in congenital disorders of glycosylation cells. J Biol Chem (2012) 0.98
Genetic modification of neural stem cells. Mol Ther (2008) 0.98
Cryptogenic liver disease in four children: a novel congenital disorder of glycosylation. Pediatr Res (2006) 0.96
Identification of a synovial fibroblast-specific protein transduction domain for delivery of apoptotic agents to hyperplastic synovium. Mol Ther (2003) 0.94
Heparan sulfate depletion amplifies TNF-alpha-induced protein leakage in an in vitro model of protein-losing enteropathy. Am J Physiol Gastrointest Liver Physiol (2004) 0.93
Clinical and molecular features of congenital disorder of glycosylation in patients with type 1 sialotransferrin pattern and diverse ethnic origins. J Pediatr (2002) 0.91
A frequent mild mutation in ALG6 may exacerbate the clinical severity of patients with congenital disorder of glycosylation Ia (CDG-Ia) caused by phosphomannomutase deficiency. Hum Mol Genet (2002) 0.90
Reduced production of sulfated glycosaminoglycans occurs in Zambian children with kwashiorkor but not marasmus. Am J Clin Nutr (2008) 0.90
Spatial regulation of Golgi phosphatidylinositol-4-phosphate is required for enzyme localization and glycosylation fidelity. Traffic (2010) 0.90
RFT1 deficiency in three novel CDG patients. Hum Mutat (2009) 0.90
The metabolic origins of mannose in glycoproteins. J Biol Chem (2014) 0.89
Mannose efflux from the cells: a potential source of mannose in blood. J Biol Chem (2011) 0.89
Potent, selective, and orally available benzoisothiazolone phosphomannose isomerase inhibitors as probes for congenital disorder of glycosylation Ia. J Med Chem (2011) 0.89
Pubertal development in ALG6 deficiency (congenital disorder of glycosylation type Ic). Mol Genet Metab (2011) 0.88
Molecular and clinical description of the first US patients with congenital disorder of glycosylation Ig. Mol Genet Metab (2004) 0.87
A zebrafish model of congenital disorders of glycosylation with phosphomannose isomerase deficiency reveals an early opportunity for corrective mannose supplementation. Dis Model Mech (2012) 0.86
Essentials of glycosylation. Semin Pediatr Neurol (2005) 0.86
N-glycosylation deficiency reduces ICAM-1 induction and impairs inflammatory response. Glycobiology (2014) 0.86
Restricted spontaneous in vitro differentiation and region-specific migration of long-term expanded fetal human neural precursor cells after transplantation into the adult rat brain. Stem Cells Dev (2009) 0.86
Identification of the first COG-CDG patient of Indian origin. Mol Genet Metab (2010) 0.86
Congenital disorder of glycosylation Ic due to a de novo deletion and an hALG-6 mutation. Biochem Biophys Res Commun (2006) 0.85
A new congenital disorder of glycosylation caused by a mutation in SSR4, the signal sequence receptor 4 protein of the TRAP complex. Hum Mol Genet (2013) 0.85
Applied glycoproteomics--approaches to study genetic-environmental collisions causing protein-losing enteropathy. Biochim Biophys Acta (2005) 0.84
New disorders in carbohydrate metabolism: congenital disorders of glycosylation and their impact on the endocrine system. Rev Endocr Metab Disord (2003) 0.84
CDG-Id in two siblings with partially different phenotypes. Am J Med Genet A (2007) 0.82
Exogenous mannose does not raise steady state mannose-6-phosphate pools of normal or N-glycosylation-deficient human fibroblasts. Mol Genet Metab (2009) 0.82
The Nuclear Overhauser Effect in the lead identification process. Curr Drug Discov Technol (2006) 0.82
Phosphoproteomic analysis: an emerging role in deciphering cellular signaling in human embryonic stem cells and their differentiated derivatives. Stem Cell Rev (2012) 0.81
Cloning and characterization of glucose transporter 11, a novel sugar transporter that is alternatively spliced in various tissues. Mol Genet Metab (2002) 0.81
Deficiency of the Cog8 subunit in normal and CDG-derived cells impairs the assembly of the COG and Golgi SNARE complexes. Traffic (2013) 0.81
Novel carboxylated N-glycans contain oligosaccharide-linked glutamic acid. Biochem Biophys Res Commun (2005) 0.81
Mannose supplements induce embryonic lethality and blindness in phosphomannose isomerase hypomorphic mice. FASEB J (2014) 0.81
Insufficient ER-stress response causes selective mouse cerebellar granule cell degeneration resembling that seen in congenital disorders of glycosylation. Mol Brain (2013) 0.81
Novel cell lines isolated from mouse embryonic stem cells exhibiting de novo methylation of the E-cadherin promoter. Stem Cells (2014) 0.80
Metabolically programmed quality control system for dolichol-linked oligosaccharides. Proc Natl Acad Sci U S A (2013) 0.80
Testing for congenital disorders of glycosylation by HPLC measurement of serum transferrin glycoforms. Clin Chem (2004) 0.80
Dissecting functions of the conserved oligomeric Golgi tethering complex using a cell-free assay. Traffic (2013) 0.80